Invesco Dorsey Wright Healthcare Momentum ETF

PTH

Market cap $98M

Overview Fund Activity

40.83 USD

+1.35

3.42%

At close Updated Sep 18, 4:00 PM EDT

1 day

3.42%

5 days

0.15%

1 month

5.07%

3 months

6.55%

6 months

4%

Year to date

0.54%

1 year

-12.87%

5 years

-9.47%

10 years

94.34%

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.24% less ownership

Funds ownership: 37.2% [Q1] → 36.96% (-0.24%) [Q2]

8% less funds holding

Funds holding: 60 [Q1] → 55 (-5) [Q2]

9% less capital invested

Capital invested by funds: $41.5M [Q1] → $37.8M (-$3.7M) [Q2]

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

50% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 22

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $556K

See Fund Rankings

Financial journalist opinion

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Healthcare Sector Checkup As U.S. Looks To Change Regulations

PTH: A Health Care Headache Worth Selling

PTH is comprised of 30+ Health Care stocks selected based on a proprietary momentum-based model. Its expense ratio is 0.60% and the ETF has $115 million in assets under management. The strategy relies on technical analysis, but that's not necessarily the issue. Instead, PTH reconstitutes quarterly, forcing managers to wait to buy stocks only after they've made their massive gains. PTH's current holdings illustrate this point perfectly. Although they've gained 51% over the last six months, the ETF itself has declined by 12% over the same period.

PTH: A Health Care Headache Worth Selling

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Zacks Investment Research

Unwrapping 5 ETF Surprises From Secret Santa for Christmas

The current dip has made many ETFs attractive, and we call them "Secret Santa." These could surprise investors with big returns this Christmas.

Unwrapping 5 ETF Surprises From Secret Santa for Christmas

Finding Opportunity in Unloved Healthcare ETFs

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

PTH: Avoid This Momentum-Based Small-Cap Health Care ETF

PTH tracks the DWA Healthcare Technical Leaders Index, selecting U.S. Health Care stocks based on a proprietary relative strength measure. There are about 300 U.S. Health Care stocks in the selection universe. The Index only requires 30, and any point, you'll see many early-stage firms delivering exceptional short-term returns. As a result, PTH holds mostly small-cap stocks with huge recent price gains. However, the flaw is its passively-managed approach that rebalances and reconstitutes on a fixed quarterly timeline.

Zacks Investment Research

6 Factors to Bet on Wall Street: ETFs to Buy

The Nasdaq Composite and the S&P 500 hit new all-time high Friday. However, there are chances of further rally.

See News Rankings

Charts implemented using Lightweight Charts™